Statistics for Cost utility analysis of long acting muscarinic antagonists (LAMAs) as an alternative to long acting beta agonists (labas) for treatment of severe COPD in the South African public sector
Total visits
| views | |
|---|---|
| Cost utility analysis of long acting muscarinic antagonists (LAMAs) as an alternative to long acting beta agonists (labas) for treatment of severe COPD in the South African public sector | 18 |
Total visits per month
| views | |
|---|---|
| February 2024 | 3 |
| March 2024 | 7 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 3 |
| July 2024 | 1 |
| August 2024 | 4 |
File Visits
| views | |
|---|---|
| MPH_COMH7175A_1946476_03.06.2023.pdf | 48 |
Top country views
| views | |
|---|---|
| South Africa | 17 |
| Norway | 1 |
Top city views
| views | |
|---|---|
| Johannesburg | 15 |
| Lenasia | 2 |